- Home
- HAYW vs AXNX Comparison
HAYW vs AXNX Comparison
Compare HAYW & AXNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HAYW
- AXNX
- Stock Information
- Founded
- HAYW 1925
- AXNX 2012
- Country
- HAYW United States
- AXNX United States
- Employees
- HAYW N/A
- AXNX N/A
- Industry
- HAYW Electronic Components
- AXNX Medical/Dental Instruments
- Sector
- HAYW Technology
- AXNX Health Care
- Exchange
- HAYW Nasdaq
- AXNX Nasdaq
- Market Cap
- HAYW 3.2B
- AXNX 3.6B
- IPO Year
- HAYW 2021
- AXNX N/A
- Fundamental
- Price
- HAYW $16.06
- AXNX $70.98
- Analyst Decision
- HAYW Hold
- AXNX Hold
- Analyst Count
- HAYW 5
- AXNX 8
- Target Price
- HAYW $16.80
- AXNX $71.00
- AVG Volume (30 Days)
- HAYW 2.4M
- AXNX 571.3K
- Earning Date
- HAYW 10-29-2024
- AXNX 11-07-2024
- Dividend Yield
- HAYW N/A
- AXNX N/A
- EPS Growth
- HAYW 40.94
- AXNX N/A
- EPS
- HAYW 0.43
- AXNX N/A
- Revenue
- HAYW $1,003,000,000.00
- AXNX $431,902,000.00
- Revenue This Year
- HAYW $5.29
- AXNX $25.35
- Revenue Next Year
- HAYW $7.08
- AXNX $19.92
- P/E Ratio
- HAYW $37.36
- AXNX N/A
- Revenue Growth
- HAYW 3.09
- AXNX 26.08
- 52 Week Low
- HAYW $11.54
- AXNX $55.09
- 52 Week High
- HAYW $16.87
- AXNX $71.05
- Technical
- Relative Strength Index (RSI)
- HAYW 58.24
- AXNX 79.35
- Support Level
- HAYW $15.88
- AXNX $70.36
- Resistance Level
- HAYW $16.22
- AXNX $70.75
- Average True Range (ATR)
- HAYW 0.52
- AXNX 0.22
- MACD
- HAYW -0.05
- AXNX 0.01
- Stochastic Oscillator
- HAYW 39.10
- AXNX 92.86
About HAYW Hayward Holdings Inc.
Hayward Holdings is a leading manufacturer of energy-efficient swimming pool equipment and pool automation systems. The company offers a wide range of pool equipment, including pumps, filters, heaters, LED lights, and sanitization. Headquartered in Charlotte, North Carolina, the company has around 2,000 full-time employees. Hayward generated approximately $1.0 billion in revenue in 2023.
About AXNX Axonics Inc.
Axonics Inc is a United States-based medical technology company. It focuses on developing and commercializing novel products for adults with bladder and bowel dysfunction, that include implantable SNM systems to treat urinary urge incontinence and urinary urgency frequency (UUF); a urethral bulking agent (Bulkamid) to treat female stress urinary incontinence. SNM therapy is predominantly used to treat patients with overactive bladder, fecal incontinence, and urinary retention. Geographically, the company generates majority of its revenue from United States and rest from International markets.